200 related articles for article (PubMed ID: 25510278)
1. Mechanisms of pre-B-cell receptor checkpoint control and its oncogenic subversion in acute lymphoblastic leukemia.
Buchner M; Swaminathan S; Chen Z; Müschen M
Immunol Rev; 2015 Jan; 263(1):192-209. PubMed ID: 25510278
[TBL] [Abstract][Full Text] [Related]
2. The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia.
Eswaran J; Sinclair P; Heidenreich O; Irving J; Russell LJ; Hall A; Calado DP; Harrison CJ; Vormoor J
Leukemia; 2015 Aug; 29(8):1623-31. PubMed ID: 25943180
[TBL] [Abstract][Full Text] [Related]
3. Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia.
Chen Z; Shojaee S; Buchner M; Geng H; Lee JW; Klemm L; Titz B; Graeber TG; Park E; Tan YX; Satterthwaite A; Paietta E; Hunger SP; Willman CL; Melnick A; Loh ML; Jung JU; Coligan JE; Bolland S; Mak TW; Limnander A; Jumaa H; Reth M; Weiss A; Lowell CA; Müschen M
Nature; 2015 May; 521(7552):357-61. PubMed ID: 25799995
[TBL] [Abstract][Full Text] [Related]
4. Rationale for targeting the pre-B-cell receptor signaling pathway in acute lymphoblastic leukemia.
Müschen M
Blood; 2015 Jun; 125(24):3688-93. PubMed ID: 25878119
[TBL] [Abstract][Full Text] [Related]
5. Dynamic pre-BCR homodimers fine-tune autonomous survival signals in B cell precursor acute lymphoblastic leukemia.
Erasmus MF; Matlawska-Wasowska K; Kinjyo I; Mahajan A; Winter SS; Xu L; Horowitz M; Lidke DS; Wilson BS
Sci Signal; 2016 Nov; 9(456):ra116. PubMed ID: 27899526
[TBL] [Abstract][Full Text] [Related]
6. BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside.
Boer JM; den Boer ML
Eur J Cancer; 2017 Sep; 82():203-218. PubMed ID: 28709134
[TBL] [Abstract][Full Text] [Related]
7. The ARF tumor suppressor in acute leukemias: insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.
Williams RT; Sherr CJ
Adv Exp Med Biol; 2007; 604():107-14. PubMed ID: 17695724
[TBL] [Abstract][Full Text] [Related]
8. The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells.
Klein F; Feldhahn N; Harder L; Wang H; Wartenberg M; Hofmann WK; Wernet P; Siebert R; Müschen M
J Exp Med; 2004 Mar; 199(5):673-85. PubMed ID: 14993251
[TBL] [Abstract][Full Text] [Related]
9. SHP2 is required for BCR-ABL1-induced hematologic neoplasia.
Gu S; Sayad A; Chan G; Yang W; Lu Z; Virtanen C; Van Etten RA; Neel BG
Leukemia; 2018 Jan; 32(1):203-213. PubMed ID: 28804122
[TBL] [Abstract][Full Text] [Related]
10. Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1.
Gu S; Chan WW; Mohi G; Rosenbaum J; Sayad A; Lu Z; Virtanen C; Li S; Neel BG; Van Etten RA
Blood; 2016 Apr; 127(14):1803-13. PubMed ID: 26773044
[TBL] [Abstract][Full Text] [Related]
11. Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells.
Feldhahn N; Klein F; Mooster JL; Hadweh P; Sprangers M; Wartenberg M; Bekhite MM; Hofmann WK; Herzog S; Jumaa H; Rowley JD; Müschen M
J Exp Med; 2005 Jun; 201(11):1837-52. PubMed ID: 15939795
[TBL] [Abstract][Full Text] [Related]
12. Targeting Kinase-activating Genetic Lesions to Improve Therapy of Pediatric Acute Lymphoblastic Leukemia.
Franca R; Kuzelicki NK; Sorio C; Toffoletti E; Montecchini O; Poropat A; Rabusin M; Curci D; Paladin D; Stocco G; Decorti G
Curr Med Chem; 2018; 25(24):2811-2825. PubMed ID: 28748759
[TBL] [Abstract][Full Text] [Related]
13. BCR/ABL1-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy.
Płotka A; Lewandowski K
Acta Haematol; 2022; 145(2):122-131. PubMed ID: 34818644
[TBL] [Abstract][Full Text] [Related]
14. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease.
Roberts KG; Pei D; Campana D; Payne-Turner D; Li Y; Cheng C; Sandlund JT; Jeha S; Easton J; Becksfort J; Zhang J; Coustan-Smith E; Raimondi SC; Leung WH; Relling MV; Evans WE; Downing JR; Mullighan CG; Pui CH
J Clin Oncol; 2014 Sep; 32(27):3012-20. PubMed ID: 25049327
[TBL] [Abstract][Full Text] [Related]
16. Pre-B cell receptor signaling in acute lymphoblastic leukemia.
Nahar R; Müschen M
Cell Cycle; 2009 Dec; 8(23):3874-7. PubMed ID: 19901533
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic stress induced by acute hyper-activation of Bcr-Abl leads to cell death upon induction of excessive aerobic glycolysis.
Dengler MA; Staiger AM; Gutekunst M; Hofmann U; Doszczak M; Scheurich P; Schwab M; Aulitzky WE; van der Kuip H
PLoS One; 2011; 6(9):e25139. PubMed ID: 21949869
[TBL] [Abstract][Full Text] [Related]
18. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.
Geng H; Brennan S; Milne TA; Chen WY; Li Y; Hurtz C; Kweon SM; Zickl L; Shojaee S; Neuberg D; Huang C; Biswas D; Xin Y; Racevskis J; Ketterling RP; Luger SM; Lazarus H; Tallman MS; Rowe JM; Litzow MR; Guzman ML; Allis CD; Roeder RG; Müschen M; Paietta E; Elemento O; Melnick AM
Cancer Discov; 2012 Nov; 2(11):1004-23. PubMed ID: 23107779
[TBL] [Abstract][Full Text] [Related]
19. ZFP521 contributes to pre-B-cell lymphomagenesis through modulation of the pre-B-cell receptor signaling pathway.
Hiratsuka T; Takei Y; Ohmori R; Imai Y; Ozeki M; Tamaki K; Haga H; Nakamura T; Tsuruyama T
Oncogene; 2016 Jun; 35(25):3227-38. PubMed ID: 26522721
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD66c and CD25 in acute lymphoblastic leukemia as a predictor of the presence of BCR/ABL rearrangement.
Owaidah TM; Rawas FI; Al Khayatt MF; Elkum NB
Hematol Oncol Stem Cell Ther; 2008; 1(1):34-7. PubMed ID: 20063526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]